From a mechanistic perspective, the eGDR, as an alternative marker for IR, not only reflects reduced insulin sensitivity but also captures multidimensional dysregulation, including glucose and lipid metabolism disorders, endothelial dysfunction, chronic inflammation, and oxidative stress [42–44]. Here, INS is linked to endothelial dysfunction.